Dataset Information

Polysulfonate Cappings on Upconversion Nanoparticles Prevent Their Disintegration in Water and Provide Superior Stability in a Highly Acidic Medium.

ABSTRACT: The stability of organic cappings on hexagonal NaYF₄:Ln³⁺ upconversion nanoparticles (UCNPs) is crucial for their luminescence efficiency in aqueous solutions. The capping removal quickens as the acidity of the medium increases. We demonstrate here that polysulfonates, namely poly(2-acrylamido-2-methyl-1-propanesulfonate) (PAMPS) and poly(sodium 4-styrene sulfonate) (PSS), remain anchored to the surface of NaYF₄:Yb³⁺,Er³⁺/Tm³ UCNPs even at a pH as low as 2 due to strong acidity of the sulfonate anchoring groups (pK _a of ca. -3). Bare UCNPs progressively disintegrate into their compositional F^-, Na⁺, Y³⁺, and Ln³⁺ ions. Their disintegration is particularly worrying in highly diluted dispersions of nanoparticles because both the lanthanide ions and/or the bare UCNPs can cause undesirable interference in a chemical or biological environment. Remarkably, the UC@PSS nanohybrid is particularly chemically stable, exhibiting an amazingly low release of Y³⁺ and Ln³⁺ ions for up to 96 h in highly diluted water dispersions (10 ?g/mL). Additional advantages of the use of PSS as capping layer are its biocompatibility and its high dispersibility in water, together with easy further functionalization of the UCNP@PSS nanohybrids.

SUBMITTER: Estebanez N

PROVIDER: S-EPMC6648593 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Polysulfonate Cappings on Upconversion Nanoparticles Prevent Their Disintegration in Water and Provide Superior Stability in a Highly Acidic Medium.

Estebanez Nestor N González-Béjar María M Pérez-Prieto Julia J

ACS omega 20190211 2

The stability of organic cappings on hexagonal NaYF4:Ln3+ upconversion nanoparticles (UCNPs) is crucial for their luminescence efficiency in aqueous solutions. The capping removal quickens as the acidity of the medium increases. We demonstrate here that polysulfonates, namely poly(2-acrylamido-2-methyl-1-propanesulfonate) (PAMPS) and poly(sodium 4-styrene sulfonate) (PSS), remain anchored to the surface of NaYF4:Yb3+,Er3+/Tm3 UCNP ...[more]

PMID: 31459525

Similar Datasets

Project description:Joint-preserving surgical treatment of complex unstable proximal humerus fractures remains challenging, with high failure rates even following state-of-the-art locked plating. Enhancement of implants could help improve outcomes. By overcoming limitations of conventional biomechanical testing, finite element (FE) analysis enables design optimization but requires stringent validation. This study aimed to computationally enhance the design of an existing locking plate to provide superior fixation stability and evaluate the benefit experimentally in a matched-pair fashion. Further aims were the evaluation of instrumentation accuracy and its potential influence on the specimen-specific predictive ability of FE. Screw trajectories of an existing commercial plate were adjusted to reduce the predicted cyclic cut-out failure risk and define the enhanced (EH) implant design based on results of a previous parametric FE study using 19 left proximal humerus models (Set A). Superiority of EH versus the original (OG) design was tested using nine pairs of human proximal humeri (N = 18, Set B). Specimen-specific CT-based virtual preoperative planning defined osteotomies replicating a complex 3-part fracture and fixation with a locking plate using six screws. Bone specimens were prepared, osteotomized and instrumented according to the preoperative plan via a standardized procedure utilizing 3D-printed guides. Cut-out failure of OG and EH implant designs was compared in paired groups with both FE analysis and cyclic biomechanical testing. The computationally enhanced implant configuration achieved significantly more cycles to cut-out failure compared to the standard OG design (p < 0.01), confirming the significantly lower peri-implant bone strain predicted by FE for the EH versus OG groups (p < 0.001). The magnitude of instrumentation inaccuracies was small but had a significant effect on the predicted failure risk (p < 0.01). The sample-specific FE predictions strongly correlated with the experimental results (R2 = 0.70) when incorporating instrumentation inaccuracies. These findings demonstrate the power and validity of FE simulations in improving implant designs towards superior fixation stability of proximal humerus fractures. Computational optimization could be performed involving further implant features and help decrease failure rates. The results underline the importance of accurate surgical execution of implant fixations and the need for high consistency in validation studies.

Project description:BackgroundHyperkalemia is a potentially life-threatening electrolyte abnormality defined as a serum potassium above the lab reference range (usually >5.0-5.5 mEq/L). Polystyrene resins, including sodium polystyrene sulfonate (SPS) and calcium polystyrene sulfonate (CPS), have long been used to treat hyperkalemia. Sodium polystyrene sulfonate/calcium polystyrene sulfonate act by exchanging a cation for potassium within the intestinal lumen. While SPS and CPS have been available since the 1960s, there are rising concerns about the validity of the data supporting its use and about serious adverse gastrointestinal effects.ObjectiveThe objective of this systematic review was to quantify the efficacy and safety of polystyrene sulfonate resins (SPS/CPS) in the treatment of adults with hyperkalemia. This review focuses on the randomized control trial (RCT), interventional non-RCT, and observational data available on SPS/CPS use.DesignSystematic review.SettingAny country of origin. Both inpatient and outpatient settings.PatientsAdults with hyperkalemia treated with polystyrene sulfonate resins.MeasurementsThe primary outcome was change in serum potassium. The secondary outcomes included adverse effects of SPS/CPS and prevention of recurrent hyperkalemia.MethodsWe conducted a systematic review using Cochrane Library, EMBASE (1947-2019), and Medline (1946-2019) databases. Literature reviews, systematic reviews, case studies, case series, and editorial pieces were excluded. Included studies were assessed for risk of bias.ResultsFour RCTs, 21 observational studies, and 5 quasi-experimental trials were included. A total of 212 351 patients were included. Two thousand and fifty-eight patients were studied for the primary outcome and 210 293 patients were studied for the secondary outcomes. Study designs were heterogeneous and not amenable to meta-analysis. Most studies included nonhemodialysis outpatients older than 65 years. Of the included studies, 22/25 (88%) demonstrated a reduction of serum potassium >0.5 mEq/L over the study period. The magnitude of reduction in serum potassium of potassium resin compared with placebo or matched controls in the 3 low-risk studies identified was 0.14 to 1.04 mEq/L. However, each study used different dosing regimens. Ten of 22 studies reported the effects of polystyrene resins on serum potassium within 24 hours. A few high-quality observational studies suggest an increased risk of serious adverse gastrointestinal events with a relative risk of 2.10 and a hazard ratio of 1.25 to 1.94; however, the absolute risk remains low. The incidence of adverse gastrointestinal events is 16 to 23 events per 1000 person-years.LimitationsWe acknowledge several limitations in this study. Case studies and case series were excluded from the search results. Large case series may have been excluded despite having comparable sample sizes to studies included due to lack of a comparator and calculated estimates. Due to the heterogeneity of the studies, the data were unable to be meta-analyzed and as such the potassium-lowering effect of polystyrene sulfonate resins remains founded on small studies with potential confounders.ConclusionsThis systematic review demonstrates a continued lack of high-quality evidence for the use of SPS/CPS in hyperkalemia. Studies investigated highly variable timelines and the most robust evidence for SPS/CPS use is in chronic hyperkalemia. While the absence of high-quality evidence does not exclude the possibility of benefit, prescribers must understand that the use of SPS/CPS in acute hyperkalemia is not supported by high-quality evidence.Trial registrationThe protocol for this systematic review was not registered.

Dataset Information

Polysulfonate Cappings on Upconversion Nanoparticles Prevent Their Disintegration in Water and Provide Superior Stability in a Highly Acidic Medium.

Publications

Polysulfonate Cappings on Upconversion Nanoparticles Prevent Their Disintegration in Water and Provide Superior Stability in a Highly Acidic Medium.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets